drugset / Trial / NCT00857571
A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.
RandomizedCrossoverOpen-labelBasic science
Summary
The study compares the plasma concentrations of PF-02413873 after administration of several doses as suspension and as tablets
Timeline
- Start
- 2009-04
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-02413873 | Unknown | 5 mg | Oral |
| Subject | PF-02413873 | Unknown | 30 mg | Oral |
| Subject | PF-02413873 | Unknown | 150 mg | Oral |
| Subject | PF-02413873 | Unknown | 400 mg | Oral |
| Subject | PF-02413873 | Unknown | 750 mg | Oral |
Indications
No indication recorded.